WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (43)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cass, W. A.
Right arrow Articles by Manning, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cass, W. A.
Right arrow Articles by Manning, M. W.

 Previous Article  |  Next Article 

The Journal of Neuroscience, September 1, 1999, 19(17):7653-7660

Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine

Wayne A. Cass and Michael W. Manning

Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536

Repeated administration of methamphetamine (METH) to animals can result in long-lasting decreases in striatal dopamine (DA) content. In addition, the evoked overflow of striatal DA is reduced in rats 1 week after neurotoxic doses of METH. However, whether these functional changes in DA release are permanent or tend to recover over time has not been established. In the present study we used in vivo electrochemistry and microdialysis to examine evoked overflow of DA in the striatum of METH-treated rats at several time points after treatment to determine if DA overflow would spontaneously recover. Male Fischer-344 rats were administered METH (5 mg/kg, s.c.) or saline four times in one day at 2 hr intervals. In vivo electrochemistry experiments in anesthetized rats, and in vivo microdialysis studies in awake rats, were carried out 1 week, 1 month, 6 months, and 12 months after treatment. At 1 week after treatment there were significant decreases in potassium- and amphetamine-evoked overflow of DA, and in clearance of DA, in the striatum of the METH-treated animals. Basal extracellular levels of DA and its metabolites were also decreased. Evoked overflow had partially recovered by 1 month. By 6 months evoked overflow of DA appeared to be normal in the METH-treated rats. However, whole tissue levels of striatal DA were still significantly decreased. All parameters were back to control values by 12 months. These results suggest that presynaptic dopaminergic functioning can recover to normal levels in the striatum of METH-treated rats by 12 months after treatment.

Key words: methamphetamine; neurotoxicity; striatum; dopamine; in vivo electrochemistry; in vivo microdialysis

Copyright © 1999 Society for Neuroscience  0270-6474/99/19177653-08$05.00/0


This article has been cited by other articles:


Home page
 Arch Gen PsychiatryHome page
T. E. Nordahl, R. Salo, Y. Natsuaki, G. P. Galloway, C. Waters, C. D. Moore, S. Kile, and M. H. Buonocore
Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study
Arch Gen Psychiatry, April 1, 2005; 62(4): 444 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
G.-J. Wang, N. D. Volkow, L. Chang, E. Miller, M. Sedler, R. Hitzemann, W. Zhu, J. Logan, Y. Ma, and J. S. Fowler
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Am J Psychiatry, February 1, 2004; 161(2): 242 - 248.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J, October 1, 2003; 17(13): 1775 - 1788.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Grondin, W. A. Cass, Z. Zhang, J. A. Stanford, D. M. Gash, and G. A. Gerhardt
Glial Cell Line-Derived Neurotrophic Factor Increases Stimulus-Evoked Dopamine Release and Motor Speed in Aged Rhesus Monkeys
J. Neurosci., March 1, 2003; 23(5): 1974 - 1980.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
J. Vinklerova, J. Novakova, and A. Sulcova
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251
J Psychopharmacol, March 1, 2002; 16(2): 139 - 143.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y.-S. Ding, et al.
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
J. Neurosci., December 1, 2001; 21(23): 9414 - 9418.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. E. Sabol, J. B. Richards, and K. Yung
The Effects of High-Dose Methamphetamine in the Aging Rat: Differential Reinforcement of Low-Rate 72-s Schedule Behavior and Neurochemistry
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 850 - 863.
[Abstract] [Full Text]


-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-